Physician profile
Ameet Kumar
NPI 1669766598
$1,465.20
in general payments reported to CMS, 2019-2025
17 companies · $82.70 in 2025
The $82.70 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.16 · 2020: $14.66 · 2021: $99.58 · 2022: $455 · 2023: $483 · 2024: $315 · 2025: $82.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $344.66 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $193.19 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.28 | 2022-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.04 | 2022-2023 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.82 | 2022-2024 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $115.32 | 2021-2023 | |
| Abbvie INC. | $108.01 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $38.32 | 2023 | Camzyos |
| Glaxosmithkline, LLC. | $37.48 | 2020-2021 | |
| Csl Behring | $34.68 | 2023 | Kcentra |
| Pfizer INC. | $33.27 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $31.38 | 2023 | Inpefa |
| Astrazeneca Pharmaceuticals Lp | $29.16 | 2022 | |
| Baxter Healthcare | $20.59 | 2022 | |
| Nestle Healthcare Nutrition INC. | $19.10 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.17 | 2025 | |
| Merck Sharp & Dohme LLC | $17.73 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameet Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.